The global thoracolumbar stabilization devices market is projected to be appraised at USD 2,066.2 million by 2033, up from USD 1,206.7 million in 2023, advancing at a CAGR of 5.5% from 2023 to 2033. The demand for thoracolumbar stabilization devices is gaining momentum as they are widely used to reduce or eliminate the instability in the spine regions and act as an alternative method for the spinal fusion.
Thoracolumbar stabilization procedure retains some of the mobility in the spine, whereas fusion eliminates all the movement with complete stabilization and the same is expected to spike the demand for the product. In addition to this, the market growth is also fostered through help by these devices in providing a firm support to the thoracic spine and straightening the curve.
Spinal injury and chronic back pain are among the prevalence conditions and increasing prevalence of these conditions is expected to drive the thoracolumbar stabilization devices market growth to a considerable extent.
Titanium devices segment is expected to be leading revenue generating market as these devices are light in weight and dynamic in nature. The demand for these devices is likely to positively impact the overall market growth.
The sales of these devices spike as posterior thoracolumbar stabilization devices are expected to generate high revenue compared to anterior devices as generally all surgical stabilization of thoracolumbar region starts with the posterior implant.
The sales of thoracolumbar stabilization devices are expected to be continuously growing due to cost effectiveness and better management of disease as compared to analgesics. These devices are available in variety of shape and size and provide options to choose among variety and the same augments the revenue of market.
Report Attributes | Details |
---|---|
Global Thoracolumbar Stabilization Devices Market Valuation in 2022 | USD 1,149.6 million |
Estimated Global Market Share in 2023 | USD 1,206.7 million |
Forecasted Global Market Size by 2033 | USD 2,066.2 million |
Projected Global Market Growth Rate from 2023 to 2033 | 5.5% CAGR |
Historical Market Growth Rate from 2018 to 2022 | 4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market outlook is positively influenced on account of the growing concern for health diseases worldwide, where governments all over the world are putting a huge emphasis on healthcare. Further, medical facilities are also constantly working to improve the standard and quality of stabilization devices.
The combined efforts of the government and medical community in tandem with the rising demand for non-invasive surgical procedures are anticipated to aid in the growth of the thoracolumbar stabilization devices market. Furthermore, the sales of thoracolumbar stabilization device are propelled by the increasing prevalence of spine deformities among older population. However, high initial cost associated with these devices can be a restraint to the market on the whole.
Regional Market Comparison | Global Market Share in Percentage |
---|---|
North America | 42.7% |
Europe | 34.1% |
North America is the leading market for the thoracolumbar stabilization devices due to presence of key players, pushing the region’s market share to 42.7% in 2022. In addition to this, the awareness among people coupled with better healthcare infrastructure and reimbursement policies are likely to expand the region’s market size to a significant extent. Also, the rising number of spinal and back injuries in this region also drives up product demand.
Regional Market Comparison | Global Market Share in Percentage |
---|---|
The United States | 40% |
Germany | 8.9% |
Japan | 2.6% |
By 2022, the market in Europe accounted for a share of 34.1% in 2022. Western Europe is the second largest market for thoracolumbar stabilization devices; owing to government funding that reaches the poor members of society who are in desperate need of such devices.
The FDA approval process for medical devices in the United States is stringent, inconsistent, and lengthy, when compared to the CE marking process in Europe which is expanding the market size in the region.
Regional Markets | CAGR (2023 to 2033) |
---|---|
The United Kingdom | 4.3% |
China | 6.7% |
India | 5.7% |
Australia | 4.6% |
Innovative medical devices frequently introduce disruptive changes to the market to significantly improve the quality of patients' lives. Moreover, numerous start-ups are bringing out emerging trends in the market with the launch of various technologies in regard to the market.
Spinal Stabilization Technologies is a start-up, situated in the United States that creates spinal medical devices to treat degenerative disc disease. PerQdisc, the company's investigational device, is a less invasive alternative to highly invasive traditional total disc replacement and spinal fusion treatments. It is a patent-pending lumbar spine disc nucleus replacement technology that replaces the physical space of the nucleus pulposus and restores anatomical motion and weight bearing capabilities.
Category | By Device Type |
---|---|
Top Segment | Anterior Stabilization Device |
Market Share in Percentage | 55.4% |
Category | By End User |
---|---|
Top Segment | Hospitals |
Market Share in Percentage | 51.2% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Companies are focusing on advancement of devices and development of minimally invasive screws and roads, thereby expanding their market share. Such recent developments by the key players in the market are as follows:
Companies are focusing on advancement of devices and development of minimally invasive screws and roads, thereby expanding their market share. Such recent developments by the key players in the market are as follows:
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 5.5% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered | By Device Type, By Material, By End Use, By Region |
Regions Covered | North America Market; Latin America Market; East Asia Market; South Asia Pacific Market; The Middle East and Africa (ME&A) Market; Europe Market |
Key Countries Profiled | The United States, Canada, Brazil, Argentina, Germany, The United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASIAN, GCC, South Africa |
Key Companies Profiled | B. Braun Melsungen AG; Zimmer, Inc.; Coligne AG; Yellowsteps SAS; Medyssey Co. Ltd.; DePuySynthes Company; Aesculap Implant Systems, LLC; Ulrich Medical; Medtronic Public Limited Company; Stryker |
Customization& Pricing | Available Upon Request |
The market is valued at USD 1,206.7 million in 2023.
From 2018 to 2022, the market registered a CAGR of 4%.
The market shall reach USD 2,066.2 million in 2033.
The market will register a 5.5% CAGR until 2033.
North America generated 42.7% revenue in 2022.
Explore Healthcare Insights
View Reports